Order Article Reprints

Joe NS, Wang Y, Oza HH, Godet I, Milki N, Riggins GJ, Gilkes DM. Mebendazole Treatment Disrupts the Transcriptional Activity of Hypoxia-Inducible Factors 1 and 2 in Breast Cancer Cells. Cancers. 2023; 15(4):1330. https://doi.org/10.3390/cancers15041330

Joe, Natalie S., Yuanfeng Wang, Harsh H. Oza, Inês Godet, Nubaira Milki, Gregory J. Riggins, and Daniele M. Gilkes. 2023. "Mebendazole Treatment Disrupts the Transcriptional Activity of Hypoxia-Inducible Factors 1 and 2 in Breast Cancer Cells" Cancers 15, no. 4: 1330. https://doi.org/10.3390/cancers15041330

Joe, N. S., Wang, Y., Oza, H. H., Godet, I., Milki, N., Riggins, G. J., & Gilkes, D. M. (2023). Mebendazole Treatment Disrupts the Transcriptional Activity of Hypoxia-Inducible Factors 1 and 2 in Breast Cancer Cells. Cancers, 15(4), 1330. https://doi.org/10.3390/cancers15041330